Article Text
Harm
Randomised controlled trial
Whether the use of unopposed oestrogen following a myocardial infarction is beneficial or harmful remains unclear, and in individual women the effects may vary according to the underlying risk profile
Statistics from Altmetric.com
Footnotes
-
Competing interests SS has in the past consulted, and presently consults with, Bayer Schering and with other manufacturers of female hormones.
-
Provenance and peer review Not commissioned; internally peer reviewed.